Number of Repetitions in Re‐Randomization Tests

In covariate-adaptive or response-adaptive randomization, the treatment assignment and outcome can be correlated. Under this situation, the re-randomization test is a straightforward and attractive method to provide valid statistical inferences. In this paper, we investigate the number of repetitions in tests. This is motivated by a group sequential design in clinical trials, where the nominal significance bound can be very small at an interim analysis. Accordingly, re-randomization tests lead to a very large number of required repetitions, which may be computationally intractable. To reduce the number of repetitions, we propose an adaptive procedure and compare it with multiple approaches under predefined criteria. Monte Carlo simulations are conducted to show the performance of different approaches in a limited sample size. We also suggest strategies to reduce total computation time and provide practical guidance in preparing, executing, and reporting before and after data are unblinded at an interim analysis, so one can complete the computation within a reasonable time frame.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Statistics
Published
2024-10-16
DOI
https://doi.org/10.1002/pst.2438
Citations
3
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
2.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Number of Repetitions in Re‐Randomization Tests

Bingjun Wang, Yujie Zhao, Yilong Zhang, Yiwen Luo
3 citations
Pharmaceutical Statistics
Statistical Methods in Clinical Trials
2.13
article

Number of Repetitions in Re‐Randomization Tests

Bingjun Wang, Yujie Zhao, Yilong Zhang, Yiwen Luo
article en
3 citations

Abstract

In covariate-adaptive or response-adaptive randomization, the treatment assignment and outcome can be correlated. Under this situation, the re-randomization test is a straightforward and attractive method to provide valid statistical inferences. In this paper, we investigate the number of repetitions in tests. This is motivated by a group sequential design in clinical trials, where the nominal significance bound can be very small at an interim analysis. Accordingly, re-randomization tests lead to a very large number of required repetitions, which may be computationally intractable. To reduce the number of repetitions, we propose an adaptive procedure and compare it with multiple approaches under predefined criteria. Monte Carlo simulations are conducted to show the performance of different approaches in a limited sample size. We also suggest strategies to reduce total computation time and provide practical guidance in preparing, executing, and reporting before and after data are unblinded at an interim analysis, so one can complete the computation within a reasonable time frame.

Pharmaceutical StatisticsVol. 24(1)
Meta (United States) (US), Decision Sciences (United States) (US)
Openalex Percentile: Top 12%
Statistical Methods in Clinical Trials
2.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Number of Repetitions in Re‐Randomization Tests — Bingjun Wang, Yujie Zhao, et al. · Pharmaceutical Statistics (2024) | TGRS Research Map | TGRS